# Inhaled Milrinone in Cardiac Surgery

> **NCT01725776** · PHASE2 · COMPLETED · sponsor: **Montreal Heart Institute** · enrollment: 40 (actual)

## Conditions studied

- Pulmonary Hypertension

## Interventions

- **DRUG:** Inhaled milrinone 5 mg

## Key facts

- **NCT ID:** NCT01725776
- **Lead sponsor:** Montreal Heart Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2012-02
- **Final completion:** 2012-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2012-11-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01725776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01725776, "Inhaled Milrinone in Cardiac Surgery". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01725776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*